- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03292042
Effectiveness of a Lifestyle Intervention, for People With SMI Who Meet Metabolic Syndrome Criteria
Impact of a Physical Health Promotion Program for People With Serious Mental Illness
The aim of this study is to evaluate the effectiveness of a lifestyle intervention, to reduce the risk of metabolic syndrome in patients with serious mental illness who receive treatment with antipsychotic medications.
The hypothesis of the study is that: the application of a physical health promotion program in people with serious mental illness, who receive treatment with antipsychotic medications, carried out by a mental health nurse, will decrease the presence of metabolic syndrome and contribute to improve their quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28034
- University Hospital Ramon y Cajal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnostic of serious mental illness.
- Treatment with antipsychotics.
- Met at least 3 of the 5 criteria of metabolic syndrome According to the NCEP ATP III definition.
Exclusion Criteria:
- Medical contraindications to exercise
- Admitted to hospital.
- intellectual disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
usual care
|
|
Experimental: Experimental Group
This group will carry out the lifestyle intervention (Physical health promotion program) during 6 months. The group will attend a session per week. |
The program has 24 sessions. Each session has two parts:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decrease of at least 3 of the 5 criteria of metabolic syndrome
Time Frame: 6 months
|
Fasting glucose ≥110 mg/dL (or receiving drug therapy for hyperglycemia) Blood pressure ≥130/85 mm Hg (or receiving drug therapy for hypertension) Triglycerides ≥150 mg/dL (or receiving drug therapy for hypertriglyceridemia) HDL-C <40 mg/dL in men or <50 mg/dL in women (or receiving drug therapy for reduced HDL-C) Waist circumference ≥102 cm in men or ≥88 cm in women
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic syndrome prevalence
Time Frame: 6 months
|
expressed as a percentage
|
6 months
|
use of antipsychotic
Time Frame: 6 months
|
Percentage of drugs prescribed by generic name
|
6 months
|
Toxic habits
Time Frame: 6 months
|
Percentage of smokers percentage of people who drink alcohol percentage of people using drugs of abuse
|
6 months
|
Quality of life improvement
Time Frame: 6 months
|
EuroQol- 5 Dimension (EQ-5D) includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
|
6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Mayo ClinicCompleted
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
Clinical Trials on Physical health promotion program
-
University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
National Yang Ming UniversityRecruiting
-
Patricia Kluding, PhDCompleted
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
University of Wisconsin, MadisonCompletedNutrition Disorders in Old AgeUnited States
-
Hacettepe UniversityCompletedPain | Fatigue | Work-Related Stress Disorder | Nurses
-
China Medical University HospitalNational Science Council, TaiwanUnknownMental Health Wellness 1Taiwan
-
Kirsehir Ahi Evran UniversitesiCompletedPhysical InactivityTurkey
-
Icahn School of Medicine at Mount SinaiAmerican Heart AssociationCompletedPromoting Cardiovascular Health in Younger Age GroupUnited States
-
University of RochesterCenters for Disease Control and PreventionNot yet recruitingWell-Being, PsychologicalUnited States